Formulation and Physical Characterization of Large Porous Particles for Inhalation

Pharmaceutical Research - Tập 16 Số 11 - Trang 1735-1742 - 1999
Vanbever, Rita1,2, Mintzes, Jeffrey D.2, Wang, Jue2, Nice, Jacquelyn2, Chen, Donghao2, Batycky, Richard3, Langer, Robert1, Edwards, David A.2
1Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge
2Department of Chemical Engineering, Pennsylvania State University, University Park
3Advanced Inhalation Research, Inc., Cambridge

Tóm tắt

Purpose. Relatively large (>5 µm) and porous (mass density < 0.4 g/cm3) particles present advantages for the delivery of drugs to the lungs, e.g., excellent aerosolization properties. The aim of this study was, first, to formulate such particles with excipients that are either FDA-approved for inhalation or endogenous to the lungs; and second, to compare the aerodynamic size and performance of the particles with theoretical estimates based on bulk powder measurements. Methods. Dry powders were made of water-soluble excipients (e.g., lactose, albumin) combined with water-insoluble material (e.g., lung surfactant), using a standard single-step spray-drying process. Aerosolization properties were assessed with a Spinhaler TM device in vitro in both an Andersen cascade impactor and an AerosizerTM.. Results. By properly choosing excipient concentration and varying the spray drying parameters, a high degree of control was achieved over the physical properties of the dry powders. Mean geometric diameters ranged between 3 and 15 µm, and tap densities between 0.04 and 0.6 g/cm3. Theoretical estimates of mass mean aerodynamic diameter (MMAD) were rationalized and calculated in terms of geometric particle diameters and bulk tap densities. Experimental values of MMAD obtained from the AerosizerTM most closely approximated the theoretical estimates, as compared to those obtained from the Andersen cascade impactor. Particles possessing high porosity and large size, with theoretical estimates of MMAD between 1−3 µm, exhibited emitted doses as high as 96% and respirable fractions ranging up to 49% or 92%, depending on measurement technique. Conclusions. Dry powders engineered as large and light particles, and prepared with combinations of GRAS (generally recognized as safe) excipients, may be broadly applicable to inhalation therapy.

Từ khóa


Tài liệu tham khảo

A. J. Hickey (ed.). Inhalation aerosols—Physical and biological basis for therapy, in Lung Biology in Health and Disease, C. Lenfant (ex. ed.) 94, 1996.

citation_journal_title=Int. J. Pharm.; citation_title=Drug delivery to the respiratory tract using dry powders inhalers; citation_author=M. P. Timsina, G. P. Martin, C. Marriot, D. Ganderton, M. Yianneskis; citation_volume=101; citation_publication_date=1994; citation_pages=1-13; citation_id=CR2

citation_journal_title=J. Aerosol Sci.; citation_title=The influence of formulation on emission, deaggregation and deposition of dry powders for inhalation; citation_author=D. L. French, D. A. Edwards, R. W. Niven; citation_volume=27; citation_publication_date=1996; citation_pages=769-783; citation_id=CR3

citation_journal_title=J. Aerosol Sci.; citation_title=Aerodynamics and aerosol particle deaggregation phenomena in model oral-pharyngeal cavities; citation_author=W.-I. Li, M. Perzl, J. Heyder, R. Langer, J. D. Brain, K.-H. Englmeier, R. W. Niven, D. A. Edwards; citation_volume=27; citation_publication_date=1996; citation_pages=1269-1286; citation_id=CR4

citation_journal_title=Science; citation_title=Large porous particles for pulmonary drug delivery; citation_author=D. A. Edwards, J. Hanes, G. Caponetti, J. Hrkach, A. Ben-Jebria, M. L. Eskew, J. D. Mintzes, D. Deaver, N. Lotan, R. Langer; citation_volume=276; citation_publication_date=1997; citation_pages=1868-1871; citation_id=CR5

citation_journal_title=Pharm. Res.; citation_title=Inhalation of large porous albuterol particles for sustained bronchodilation; citation_author=A. Ben-Jebria, D. Chen, M.-L. Eskew, R. Vanbever, R. Langer, D. A. Edwards; citation_volume=16; citation_publication_date=1999; citation_pages=555-561; citation_id=CR6

citation_journal_title=J. Aerosol Med.; citation_title=Inhalation of estradiol for sustained systemic delivery; citation_author=J. Wang, A. Ben-Jebria, D. A. Edwards; citation_volume=12; citation_publication_date=1999; citation_pages=27-32; citation_id=CR7

citation_journal_title=Intern. Symp. Control. Rel. Bioact. Mater.; citation_title=Sustained-release of insulin from insoluble inhaled particles; citation_author=R. Vanbever, A. Ben-Jebria, J. D. Mintzes, R. Langer, D. A. Edwards; citation_volume=25; citation_publication_date=1998; citation_pages=261-262; citation_id=CR8

European Pharmacopoeia, 3rd edition, addendum 1999, 74–77.

citation_inbook_title=Topics in Pharmaceutical Sciences 1991; citation_publication_date=1992; citation_id=CR10; citation_author=I. Gonda; citation_publisher=Medpharm Scientific

H. Brenner and D. A. Edwards, Macrotransport Processes, Butterworth-Heinemann, 1993.

K. Masters Spray drying handbook (5th. ed.), Longman Scientific and Technical, 1991.

M. Sacchetti and M. M. Van Oort. Spray-drying and supercritical fluid particle generation techniques. In: A. J. Hickey (ed), Inhalation Aerosols, Marcel Dekker, 1996, 337–384.

citation_journal_title=Pharm. Res.; citation_title=The effect of formulation excipients on protein stability and aerosol performance of spray-dried powders of a recombinant humanized anti-IgE monoclonal antibody; citation_author=J. D. Andya, Y.-F. Maa, H. R. Costantino, P.-A. Nguyen, N. Dasovich, T. D. Sweeney, C. C. Hsu, S. J. Shire; citation_volume=16; citation_publication_date=1999; citation_pages=350-358; citation_id=CR14

citation_journal_title=J. Aerosols Sci.; citation_title=Modelling and deposition of inhaled powders drug aerosols; citation_author=A. R. Clark, M. Egan; citation_volume=25; citation_publication_date=1994; citation_pages=175-186; citation_id=CR15

citation_journal_title=J. Appl. Poly. Sci.; citation_title=Polyanhydride microspheres. IV. Morphology and characterization of systems made by spray drying; citation_author=E. Mathiowitz, H. Bernstein, S. Giannos, P. Dor, T. Turek, R. Langer; citation_volume=45; citation_publication_date=1992; citation_pages=125-134; citation_id=CR16

citation_journal_title=J. Pharm. Sci.; citation_title=Spray drying of airliquid interface sensitive recombinant human growth hormone; citation_author=Y.-F. Maa, P.-A. Nguyen, S. W. Hsu; citation_volume=87; citation_publication_date=1998; citation_pages=152-159; citation_id=CR17

citation_journal_title=Int. J. Pharm.; citation_title=Albumin microspheres as a means of drug delivery to the lung: analysis of the effects of process variables on particle sizes using factorial design methodology; citation_author=X. M. Zeng, G. P. Martin, C. Marriot; citation_volume=107; citation_publication_date=1994; citation_pages=205-210; citation_id=CR18

citation_journal_title=Int. J. Pharm.; citation_title=Tetrandrine delivery to the lung: The optimisation of albumin microspheres preparation by central composite design; citation_author=X. M. Zeng, G. P. Martin, C. Marriot; citation_volume=109; citation_publication_date=1994; citation_pages=135-145; citation_id=CR19

J. A. Clements and R. J. King. Composition of the surface active material. In: R. G. Crystal (ed.), The Biochemical Basis of Pulmonary Function, Marcel Dekker, Inc, 1976, chap 10.

citation_journal_title=J. Appl. Physiol.; citation_title=Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution; citation_author=S. I. Rennard, G. Basset, D. Lecossier, K. M. O'Donnell, P. Pinkston, P. G. Martin, R. G. Crystal; citation_volume=60; citation_publication_date=1986; citation_pages=532-538; citation_id=CR21

citation_journal_title=Acta Oto-laryng; citation_title=The daily amount of tracheo-bronchial secretions in man; citation_author=N. J. Toremalm; citation_volume=158; citation_issue=suppl.; citation_publication_date=1960; citation_pages=43-53; citation_id=CR22

citation_journal_title=Adv. Drug Del Rev.; citation_title=Mechanisms of macromolecule absorption by the lungs; citation_author=J. S. Patton; citation_volume=19; citation_publication_date=1996; citation_pages=3-36; citation_id=CR23

E. R. Weibel. Morphometry of the Human Lung, New York Academic Press, 1963.

R. J. Mason and M. C. Williams. Alveolar type II cells. In: R. G. Crystal, J. R. West et al (eds), The lung: scientific foundations, New York Raven Press Ltd, 1991, Chap. 3.1.9.

G. Scheuch, T. Meyer, K. Sommerer, H. Lichte, A. Pohner, W. Hess, P. Brand, G. Caponetti, K. Haussinger, J. Heyder, R. Batycky, R. Niven, and D. A. Edwards. Measuring in vivo deposition of large porous particles. Presented at the Biannual ISAM Meeting, Vienna, June 12–16, 1999).

Thông tin
Thông tin xuất bản

Pharmaceutical Research

Tập 16 Số 11

1735-1742

Thông tin tác giả